Rockwell Medical (RMTI) Debt to Equity (2013 - 2026)

Rockwell Medical has reported Debt to Equity for 11 years, with the latest figure at $0.25 in Q1 2026.

• For the quarter ending Q1 2026, Debt to Equity fell 28.73% year-over-year to $0.25; the trailing twelve-month figure through Mar 2026 stood at $0.25 (down 28.73% YoY), and the FY2025 full-year result was $0.24, down 28.28% from the prior year.
• Debt to Equity for Q1 2026 stood at $0.25, up from $0.24 in the prior quarter.
• The five-year high for Debt to Equity was $0.98 in Q2 2023, with the low at -$3.83 in Q1 2022.
• Historically, Debt to Equity has averaged $0.24 across 5 years, with a median of $0.37 in 2025.
• Annual changes were most pronounced in 2022 — Debt to Equity tumbled 572.62% — and 2023, when it soared 119.32%.
• Rockwell Medical's Debt to Equity stood at $0.54 in 2022, then dropped by 5.35% to $0.51 in 2023, then tumbled by 34.36% to $0.33 in 2024, then fell by 28.28% to $0.24 in 2025, then gained by 4.16% to $0.25 in 2026.
• The last three Debt to Equity figures came in at $0.25 (Q1 2026), $0.24 (Q4 2025), and $0.28 (Q3 2025), per Business Quant data.